Search

Search Constraints

You searched for: Author/Creator Magnin, Eloi

Search Results

1. [P1–240]: CLINICAL IMPACT OF CEREBROSPINAL FLUID BIOMARKERS IN MILD COGNITIVE IMPAIRMENT DIAGNOSIS. (1st July 2017)

2. Added value of 18F‐florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study. Issue 3 (26th October 2017)

3. Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage. Issue 5 (10th January 2018)

4. Cerebrospinal Fluid Levels of Kininogen‐1 Indicate Early Cognitive Impairment in Parkinson's Disease. Issue 11 (15th August 2020)

6. Consensus classification of posterior cortical atrophy. Issue 8 (1st March 2017)

7. Contribution of cerebrospinal fluid Alzheimer biomarkers to the diagnosis of Creutzfeldt‐Jakob disease. (31st December 2021)

8. Diabetes Mellitus and Cognition: Pathway Analysis in the MEMENTO Cohort. (24th August 2021)

9. F2‐03‐04: Genetic risk factors for posterior cortical atrophy. (1st July 2015)

10. Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease. Issue 8 (16th March 2016)